Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lupin

Lupin
1968 FOUNDED
PUBLIC STATUS
15K-20K EMPLOYEES
500257 STOCK SYMBOL
25 INVESTMENTS
$10.81 SHARE PRICE (As of Wednesday Closing)
Description

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The vast majority of the company's sales are derived from its Advance Markets Formulations segment, followed by Domestic Formulations. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Stock Exchange
BOM
Primary Office
  • B/4 Laxmi Towers
  • Bandra Kurla Complex
  • Mumbai, Maharashtra 400051
  • India

+91 022 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lupin’s full profile, request a free trial.

Lupin Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$10.38 - $13.71 $4.89B $10.66 -$0.15 119K 453M

Lupin Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
FY 2016
31-Mar-2016
Enterprise Value 6,219,081 5,918,706 11,001,250 9,788,625
Revenue 2,348,077 2,450,165 2,589,170 2,159,342
EBITDA 506,421 274,845 680,315 587,980
Net Income (68,139) 38,972 381,272 345,446
Total Assets 4,040,506 4,102,843 3,407,304
Total Debt 1,097,134 1,228,371 1,072,168
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lupin Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Lupin‘s full profile, request access.

Request full access to PitchBook

Lupin Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aurobindo Pharma Corporation Hyderabad, India 00000
00000 Corporate Backed or Acquired Mumbai, India 00000 00000000
000000 000000 Corporation Mumbai, India 0000
0000000 0000000000 Corporation Ahmedabad, India 00000 0000 00000000000 0000
0000000 000000 Corporation Bangalore, India 0000 000.00 000000000 000.00
To view this company’s complete list of competitors, request access »

Lupin Investments & Acquisitions (25)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 11-Oct-2017 000000000000000000 00000 Drug Discovery 000000 00000
00000000 & 0000000 03-Aug-2016 000000000 00000 00 00000 Biotechnology 000000 00000
0000000 00000'0 (0 24-Jul-2015 000000000000000000 Medical Supplies 000000 00000
00000 000000000000 23-Jul-2015 000000000000000000 00000 Pharmaceuticals 000000 00000
Novel Laboratories 23-Jul-2015 Merger/Acquisition Pharmaceuticals 000000 00000
To view this company’s complete investment and acquisition history, request access »

Lupin Subsidiaries (11)

Company Name Industry Location Founded
Symbiomix Therapeutics Drug Discovery Newark, NJ 2012
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
0000000 000000 Distributors (Healthcare) Camberwell, Australia 0000
000000 Drug Delivery Oldenzaal, Netherlands 0000
To view this company’s complete subsidiary history, request access »

Lupin Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Lupin‘s full profile, request access.

Request full access to PitchBook

Lupin Executive Team (18)

Name Title Board
Seat
Contact
Info
Vinita Gupta Chief Executive Officer & Board Member
Vinod Dhawan President Asia Africa Middle East and Latin America
Ramesh Swaminathan Board Member, Chief Financial Officer & Executive Director
Krunal Parekh General Manager, Operations (APAC & Japan), Business Development, Mergers and Acquisitions
Nilesh Gupta Managing Director

3 Former Executives

You’re viewing 5 of 18 executives. Get the full list »

Lupin Board Members (9)

Name Representing Role Since Contact
Info
000000 000000 Self Independent Director 000 0000
0000-000 000000000 Self Independent Director 000 0000
00000 000000 00.0 Lupin Vice Chairman 000 0000
0. 0. 0000 00.0 Self Independent Director 000 0000
0 0 00000 Self Independent Director 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »